We have assembled the best investigators and technology at the UT Southwestern Medical Center at Dallas to focus on a major medical problem in the U.S.-- obesity and the metabolic syndrome. This application will create mechanisms to bring together diverse groups of investigators to investigate the behavioral, metabolic, and molecular events that cause obesity and the metabolic syndrome. The major focus of this effort will be on the brain and liver, organs that both play central roles in the development of obesity and its adverse metabolic consequences. Our goals are to better understand how the brain regulates food intake and energy expenditure and to reveal how dysregulation of glucose and lipid metabolism in the liver contributes to the development of the metabolic syndrome. To address these objectives, we have developed four research teams that vary in approaches and expertise who will interact extensively to pursue the shared goals of this project. Collaborations among investigators will occur on two levels. Within each team, extensive exchanges between investigators will foster direct collaborative efforts. Interactions will also occur between the four major teams to capitalize on the diverse expertise within each of the four groups and to provide comprehensive approaches to our major objectives. To achieve these goals, we have established the Taskforce for Obesity Research at Southwestern (TORS). TORS will cement bonds among the traditionally disparate disciplines of neuroendocrinology, genetics, lipid metabolism, intermediary metabolism, and clinical epidemiology into a cohesive center to study obesity and the metabolic syndrome. Over the next three years, the major objectives will be to: 1) develop a program to foster interdisciplinary interactions at UT Southwestern to study obesity and the metabolic syndrome; 2) develop a state-of-the-art program to elucidate the metabolic and molecular basis of obesity and the metabolic syndrome using genetically modified mice; and 3) support the translation of scientific findings made in animal models to humans.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR020691-02
Application #
7171430
Study Section
Special Emphasis Panel (ZRR1-BT-B (01))
Project Start
2005-08-01
Project End
2006-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$600,440
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Bookout, Angie L; de Groot, Marleen H M; Owen, Bryn M et al. (2013) FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med 19:1147-52
Ramos-Roman, Maria A; Sweetman, Lawrence; Valdez, Maressa J et al. (2012) Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity. Metabolism 61:202-12
Ding, Xunshan; Boney-Montoya, Jamie; Owen, Bryn M et al. (2012) ?Klotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab 16:387-93
Sunny, Nishanth E; Parks, Elizabeth J; Browning, Jeffrey D et al. (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804-10
Fon Tacer, Klementina; Bookout, Angie L; Ding, Xunshan et al. (2010) Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24:2050-64
Livingston, Edward H (2009) Bariatric surgery outcomes at designated centers of excellence vs nondesignated programs. Arch Surg 144:319-25; discussion 325
Potthoff, Matthew J; Inagaki, Takeshi; Satapati, Santhosh et al. (2009) FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 106:10853-8
Zhao, Liping; Kim, Ki Woo; Ikeda, Yayoi et al. (2008) Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. Mol Endocrinol 22:1403-15
Bingham, Nathan C; Anderson, Kimberly K; Reuter, Anne L et al. (2008) Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149:2138-48
Inagaki, Takeshi; Dutchak, Paul; Zhao, Guixiang et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5:415-25

Showing the most recent 10 out of 15 publications